Lakewood Capital Management LP acquired a new stake in Cigna Group (NYSE:CI – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm acquired 427,807 shares of the health services provider’s stock, valued at approximately $117,938,000. Cigna Group makes up 6.1% of Lakewood Capital Management LP’s portfolio, making the stock its biggest holding.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CI. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at $25,000. Osbon Capital Management LLC bought a new position in shares of Cigna Group in the 2nd quarter worth $26,000. Cedar Mountain Advisors LLC grew its stake in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Cigna Group during the second quarter worth $29,000. Finally, Fiduciary Financial Advisors bought a new stake in Cigna Group in the second quarter valued at about $29,000. 86.99% of the stock is owned by institutional investors.
Cigna Group Price Performance
NYSE CI opened at $280.32 on Tuesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market cap of $74.07 billion, a price-to-earnings ratio of 11.60, a PEG ratio of 0.95 and a beta of 0.29. The business has a 50 day simple moving average of $283.92 and a 200 day simple moving average of $281.48. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is currently 25.82%.
Analysts Set New Price Targets
Several equities analysts have weighed in on CI shares. Royal Bank Of Canada increased their target price on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Sanford C. Bernstein upped their price target on Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Wolfe Research reiterated an “outperform” rating and issued a $315.00 price target on shares of Cigna Group in a research report on Tuesday, June 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Finally, Morgan Stanley boosted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $339.45.
Read Our Latest Analysis on Cigna Group
Insiders Place Their Bets
In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 23,012 shares of company stock valued at $6,386,550. Company insiders own 0.60% of the company’s stock.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
